NCT02144454

Brief Summary

Cardiovascular disease (CVD) is the leading cause of death in women. Premenopausal women have a lower risk of CVD compared with men of a similar age. However, the incidence of CVD increases greatly after the menopause. The risk of heart disease is strongly associated with the health of an individual's blood vessels. It is thought that changes to the type of fat the investigators eat in their diet may affect the normal functioning and elasticity of the blood vessels, as well as affect cholesterol levels in the blood. Types of fat in the diet include monounsaturated fats (found mainly in olive oil), n-6 polyunsaturated fats (found mainly in sunflower oil) and saturated fats (found mainly in dairy products, such as butter and cheese). Since the investigators are in the fed (or postprandial) state for up to 18 hours of the day, it is important to see how these different fats affect the investigators blood vessels and blood fats over the course of the day after eating a meal. The aim of this study is to determine how consuming meals rich in saturated fats, n-6 polyunsaturated fats or monounsaturated fats influence the normal functioning and elasticity of the blood vessels throughout the day in postmenopausal women. A secondary aim is to determine the effects of these different dietary fats on a range of accepted heart disease risk markers including circulating levels of fats (lipids) and glucose in the blood.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 22, 2014

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

December 3, 2015

Status Verified

December 1, 2015

Enrollment Period

1.3 years

First QC Date

May 15, 2014

Last Update Submit

December 2, 2015

Conditions

Keywords

Cardiovascular diseaseFatty acidsVascular functionBlood pressurePlasma lipidsInsulin resistanceEndothelial activation

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in vascular reactivity measured by flow-mediated dilatation (FMD)

    Acute study: measured at 0 (baseline), 180, 300 and 420 min

Secondary Outcomes (8)

  • Change from baseline in vascular reactivity measured by laser Doppler imaging with iontophoresis of acetylcholine (endothelium-dependent) and sodium nitroprusside (endothelium-independent)

    Acute study: measured at 0 (baseline), 240 and 450 min

  • Change from baseline in plasma lipids (primarily triacylglycerol, apolipoprotein B and non-esterified fatty acids)

    Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min

  • Change from baseline in arterial stiffness measured by digital volume pulse (stiffness index and reflection index)

    Acute study: taken at 0 (baseline), 240 amd 450 min

  • Change from baseline in blood pressure (systolic blood pressure, diastolic blood pressure and pulse pressure)

    Acute study: taken at 0 (baseline), 240 and 450 min

  • Change from baseline in markers of insulin resistance (glucose, insulin, indices of insulin resistance/sensitivity)

    Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min

  • +3 more secondary outcomes

Study Arms (3)

Meal rich in saturated fats

ACTIVE COMPARATOR

Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in saturated fats

Dietary Supplement: Saturated fat

Meal rich in monounsaturated fats

EXPERIMENTAL

Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in monounsaturated fats

Dietary Supplement: Monounsaturated fat

Meal rich in n-6 polyunsaturated fats

EXPERIMENTAL

Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in n-6 polyunsaturated fats

Dietary Supplement: n-6 polyunsaturated fat

Interventions

Saturated fatDIETARY_SUPPLEMENT
Also known as: SFA
Meal rich in saturated fats
Monounsaturated fatDIETARY_SUPPLEMENT
Also known as: MUFA
Meal rich in monounsaturated fats
n-6 polyunsaturated fatDIETARY_SUPPLEMENT
Also known as: n-6 PUFA
Meal rich in n-6 polyunsaturated fats

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal (not menstruated for at least 1 year)
  • Plasma triacylglycerol (TAG) between 0.8 and 4.0 mmol/l
  • Body mass index (BMI) between 18-35 kg/m2
  • Total cholesterol (TC): \<8 mmol/l
  • Systolic blood pressure \<160 mmHg and diastolic blood pressure \<100 mmHg
  • Non-smoker

You may not qualify if:

  • Having suffered a myocardial infarction/stroke in the past 12 months
  • Diabetic (diagnosed as fasting blood glucose \>7 mmol/l) or suffering from other endocrine disorders
  • Suffering from renal or bowel disease or have a history of cholestatic liver or pancreatitis
  • On drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
  • History of alcohol abuse
  • On hormone replacement therapy (HRT)
  • Planning or on a weight reducing regime
  • Taking nutritional supplements (e.g. fish oil, calcium)
  • Anaemic: haemoglobin \<11.5 g/dl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Reading

Reading, Berkshire, RG6 6AP, United Kingdom

Location

Related Publications (2)

  • Rathnayake KM, Weech M, Lovegrove JA, Jackson KG. Glu298Asp (rs1799983) Polymorphism Influences Postprandial Vascular Reactivity and the Insulin Response to Meals of Varying Fat Composition in Postmenopausal Women: Findings from the Randomized, Controlled Dietary Intervention and VAScular function (DIVAS)-2 Study. J Nutr. 2021 Apr 8;151(4):848-856. doi: 10.1093/jn/nxaa394.

  • Rathnayake KM, Weech M, Jackson KG, Lovegrove JA. Meal Fatty Acids Have Differential Effects on Postprandial Blood Pressure and Biomarkers of Endothelial Function but Not Vascular Reactivity in Postmenopausal Women in the Randomized Controlled Dietary Intervention and VAScular function (DIVAS)-2 Study. J Nutr. 2018 Mar 1;148(3):348-357. doi: 10.1093/jn/nxx042.

MeSH Terms

Conditions

Cardiovascular DiseasesInsulin Resistance

Interventions

Fatty Acids

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Lipids

Study Officials

  • Julie A Lovegrove, BSc PhD RNutr

    University of Reading

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Julie Lovegrove

Study Record Dates

First Submitted

May 15, 2014

First Posted

May 22, 2014

Study Start

June 1, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

December 3, 2015

Record last verified: 2015-12

Locations